CIK 0000315545
- Non-accelerated filer
- Smaller reporting company
PROVECTUS BIOPHARMACEUTICALS, INC.
Sign in to watch- Ticker
- PVCT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900031917
- Phone
- +1 866-594-5999
- Business address
- 800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
- Former names
- PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-28 | Pershing Edward Director | Option exercise · 8% Unsecured Convertible Promissory Note | −0 | |||
| 2023-07-28 | Pershing Edward Director | Option exercise · Series D-1 Convertible Preferred Stock | +28,326 | 563,891 | ||
| 2023-07-24 | Pershing Edward Director | Option exercise · 8% Unsecured Convertible Promissory Note | −0 | |||
| 2023-07-24 | Pershing Edward Director | Option exercise · Series D-1 Convertible Preferred Stock | +56,639 | 535,565 | ||
| 2023-07-20 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $125,000.00 | $0 | |
| 2023-06-30 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $125,000.00 | $0 | |
| 2023-06-15 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $125,000.00 | $0 | |
| 2023-05-26 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $50,000.00 | $0 | |
| 2023-05-12 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $200,000.00 | $0 | |
| 2023-05-08 | Morris Jeffrey Allen 10% owner | Conversion | +188,757 | $2.86 | $540K | 3,995,747 |
| 2023-04-25 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $100,000.00 | $0 | |
| 2023-04-06 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $125,000.00 | $0 | |
| 2023-03-17 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $125,000.00 | $0 | |
| 2023-02-27 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $100,000.00 | $0 | |
| 2023-02-17 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $125,000.00 | $0 | |
| 2023-01-26 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $125,000.00 | $0 | |
| 2023-01-12 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $125,000.00 | $0 | |
| 2022-12-22 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $25,000.00 | $0 | |
| 2022-12-19 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $100,000.00 | $0 | |
| 2022-12-02 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $150,000.00 | $0 |
Page 11 of 17 · 329 trades